Identification of proteins and signalling pathways involved in neoadjuvant chemotherapy responsiveness of breast tumours using proteomics

被引:0
|
作者
CR Greenwood
LC Alldridge
S Chandra Sekharan
K Al-Janabi
P Sauven
S Souchelnytskyi
机构
[1] Anglia Ruskin University,Department of Histopathology
[2] Helen Rollason Cancer Research Lab,undefined
[3] Griffith University,undefined
[4] Essex County Hospital,undefined
[5] Broomfield Hospital,undefined
[6] Broomfield Hospital,undefined
[7] Karolinska Institute,undefined
来源
关键词
Breast Cancer; Pathway Analysis; Core Biopsy; Disease Group; Ingenuity Pathway Analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Evaluation of response to neoadjuvant chemotherapy using breast scintigraphy in breast cancer
    Baena-Cañada, JM
    Partida-Palma, F
    Palomo-González, MJ
    Benítez, E
    Rueda-Ramos, A
    García-Curiel, A
    MEDICINA CLINICA, 2005, 125 (16): : 601 - 605
  • [32] Proteomics-based characterization of pathways involved in tamoxifen resistance in breast cancer cells
    Sanchez, Betzabe C.
    Johansson, Henrik
    Lehtio, Janne
    Stal, Olle
    Linderholm, Barbro K.
    CANCER RESEARCH, 2010, 70
  • [33] Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
    Xing, Ai-Yan
    Wang, Bin
    Li, Yu-Hong
    Chen, Xu
    Wang, Ya-Wen
    Liu, Hai-Ting
    Gao, Peng
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [34] Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer
    Tibau, Ariadna
    Lopez-Vilar, Laura
    Perez-Olabarria, Maitane
    Vazquez, Tania
    Pons, Cristina
    Gich, Ignasi
    Alonso, Carmen
    Ojeda, Belen
    Ramon y Cajal, Teresa
    Lerma, Enrique
    Barnadas, Agusti
    Escuin, Daniel
    NEOPLASIA, 2014, 16 (10): : 861 - 867
  • [35] Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis
    Chiba, Akiko
    Bawaneh, Alaa
    Velazquez, Christine
    Clear, Kenysha Y. J.
    Wilson, Adam S.
    Howard-McNatt, Marissa
    Levine, Edward A.
    Levi-Polyachenko, Nicole
    Yates-Alston, Shaina A.
    Diggle, Stephen P.
    Soto-Pantoja, David R.
    Cook, Katherine L.
    MOLECULAR CANCER RESEARCH, 2020, 18 (01) : 130 - 139
  • [36] Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis
    Cha, Hyo Kyeong
    Cheon, Seongmin
    Kim, Hyeyoon
    Lee, Kyung-Min
    Ryu, Han Suk
    Han, Dohyun
    MOLECULES, 2022, 27 (06):
  • [37] Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells
    Sheweita, Salah A.
    Ammar, Rania G.
    Sabra, Sally A.
    Sultan, Ahmed S.
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2021, 16 (01): : 112 - 120
  • [38] The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile
    Mathieu, MC
    Rouzier, R
    Llombart-Cussac, A
    Sideris, L
    Koscielny, S
    Travagli, JP
    Contesso, G
    Delaloge, S
    Spielmann, M
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (03) : 342 - 351
  • [39] Relationship between immune checkpoint proteins and neoadjuvant chemotherapy response in breast cancer
    Kilicaslan, Umut Kina
    Aru, Basak
    Aksu, Sibel Aydin
    Aker, Fugen Vardar
    Demirel, Gulderen Yanikkaya
    Gurleyik, Meryem Gunay
    SURGICAL ONCOLOGY-OXFORD, 2024, 52
  • [40] Apoptosis and proliferation related-proteins in breast carcinoma with neoadjuvant chemotherapy.
    Adrover, E
    Peiró, G
    Aranda, FI
    Alenda, C
    Peiro, MF
    Paya, A
    Segui, J
    Benlloch, S
    Garcia-Franco, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 87S - 87S